Intention to treat population (n=732) | Per cent | Study Population (n=522) | Per cent | Patients excluded from analyses (n=180) | Per cent | |
---|---|---|---|---|---|---|
Clinical Stage (n, %) | ||||||
Staging not completed | 13 | 1.8 | 9 | 1.6 | 4 | 2.2 |
IA | 76 | 10.4 | 56 | 10.1 | 20 | 11.1 |
IB | 50 | 6.8 | 36 | 6.5 | 14 | 7.8 |
IIA | 44 | 6.0 | 35 | 6.3 | 9 | 5.0 |
IIB | 54 | 7.4 | 44 | 8.0 | 10 | 5.6 |
IIIA | 116 | 15.8 | 95 | 17.2 | 21 | 11.7 |
IIIB | 82 | 11.2 | 70 | 12.7 | 12 | 6.7 |
IV | 297 | 40.6 | 207 | 37.5 | 90 | 50.0 |
UICC, Union for International Cancer Control.